Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.

Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.

Item

http://www.wikidata.org/entity/Q37076189

Q37076189

about

Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study Cardiovascular Diagnosis and Therapy (CDT) Editorial: the Minimalist Immediate Mechanical Intervention study.Effects of Ticagrelor on Myocardial Infarct Size.Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.

P2860

Q36205883-9BA8793B-1F04-475A-8793-736BF1B1CD9A Q42333643-0ACB5BF4-AF6F-4C65-8E1A-DAE4485EE769 Q42364551-73E1E417-C588-4CE2-8B15-683E9A8B527B Q47139749-F7784B06-F10C-4F53-AC17-D618A8E3B544

P2860

Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.

Item

http://www.wikidata.org/entity/Q37076189

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en-gb

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@nl

type

Item

label

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en-gb

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@nl

prefLabel

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en-gb

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@nl

P1154

2-s2.0-84982147578

http://www.w3.org/2001/XMLSchema#string

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Infarct Size Following Treatme ...... farction in the CvLPRIT Study.

@en

P2093

Anthony H Gershlick

http://www.w3.org/2001/XMLSchema#string

Charles Peebles

http://www.w3.org/2001/XMLSchema#string

Damian J Kelly

http://www.w3.org/2001/XMLSchema#string

Daniel Blackman

http://www.w3.org/2001/XMLSchema#string

Florence Y Lai

http://www.w3.org/2001/XMLSchema#string

Howard Swanton

http://www.w3.org/2001/XMLSchema#string

Jamal N Khan

http://www.w3.org/2001/XMLSchema#string

Joyce Wong

http://www.w3.org/2001/XMLSchema#string

Marcus Flather

http://www.w3.org/2001/XMLSchema#string

Nick Curzen

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy

CMR of microvascular obstruction and hemorrhage in myocardial infarction.

Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention.

P31

scholarly article

P356

10.1161/JAHA.116.003403

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John P. Greenwood

Gerry P McCann

Miles Dalby

P5530

8425937

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034379344

http://www.w3.org/2001/XMLSchema#string

P698

27247336

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

P932

4937278

http://www.w3.org/2001/XMLSchema#string

P953

107609/